Dashboard
Manage Tickers

ELUTELUTIA INC.

Nasdaq aziyo.com


$ 4.26 $ 0.22 (5.45 %)    

Friday, 06-Sep-2024 15:57:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 4.26
$ 4.14 x 100
-- x --
-- - --
$ 1.10 - $ 5.24
38,878
na
145.1M
$ 0.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-11-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-08-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-20-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-elutia-maintains-10-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/06/2024 13:46:23

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $10 price target.

elutia-announces-first-patient-implant-of-elupro
Elutia Announces First Patient Implant Of ...
09/05/2024 20:06:07

cantor-fitzgerald-maintains-overweight-on-elutia-lowers-price-target-to-10
Cantor Fitzgerald Maintains Overweight on ...
08/08/2024 15:29:57

Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and lowers the price target from $11 ...

elutia-q2-2024-gaap-eps-114-misses-033-estimate-sales-6291m-miss-6650m-estimate
Elutia Q2 2024 GAAP EPS $(1.14) Misses $(0...
08/07/2024 22:00:18

Elutia (NASDAQ:ELUT) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(0.33) by 2...

elutia-fully-exercises-warrants-generating-157m-in-gross-proceeds
Elutia Fully Exercises Warrants, Generatin...
08/01/2024 20:47:18

Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix products, today anno...

lake-street-maintains-buy-on-elutia-raises-price-target-to-10
Lake Street Maintains Buy on Elutia, Raise...
06/21/2024 14:08:16

Lake Street analyst Frank Takkinen maintains Elutia (NASDAQ:ELUT) with a Buy and raises the price target from $5 to $10.

cantor-fitzgerald-maintains-overweight-on-elutia-raises-price-target-to-11
Cantor Fitzgerald Maintains Overweight on ...
06/20/2024 11:57:32

Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and raises the price target from $5 t...

cantor-fitzgerald-maintains-overweight-on-elutia-raises-price-target-to-11
Cantor Fitzgerald Maintains Overweight on ...
06/18/2024 20:57:41

Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and raises the price target from $5 t...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
06/17/2024 12:07:49

elutia-received-fda-clearance-of-elupro
Elutia Received FDA Clearance of EluPro
06/17/2024 12:03:32

EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic...

elutia-announces-1326m-registered-direct-offering-of-3175m-shares-of-class-a-stock-at-340share-and-725k-prefunded-warrants-to-purchase-725k-shares-at-3399share
Elutia Announces $13.26M Registered Direct...
06/17/2024 12:02:59

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/11/2024 16:31:11

cantor-fitzgerald-maintains-overweight-on-elutia-lowers-price-target-to-5
Cantor Fitzgerald Maintains Overweight on ...
05/10/2024 15:05:17

Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and lowers the price target from $6 t...

elutia-q1-2024-gaap-eps-075-misses-041-estimate-sales-6694m-beat-6100m-estimate
Elutia Q1 2024 GAAP EPS $(0.75) Misses $(0...
05/09/2024 22:17:56

Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.41) by 8...

recap-elutia-q4-earnings
Recap: Elutia Q4 Earnings
03/07/2024 21:25:17

elutia-q4-2023-gaap-eps-0660-misses-0280-estimate-sales-5875m-miss-6550m-estimate
Elutia Q4 2023 GAAP EPS $(0.660) Misses $(...
03/07/2024 21:23:09

Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.660) per share which missed the analyst consensus estimate of $(0.280) by...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

preview-elutias-earnings
Preview: Elutia's Earnings
03/06/2024 19:01:22

elutia-regains-compliance-with-nasdaqs-market-value-of-listed-securities-requirement-and-majority-independent-board-requirement
Elutia Regains Compliance With Nasdaq's Ma...
01/10/2024 21:06:21

elutia-submits-cangaroorm-antibiotic-eluting-biomatrix-for-fda-clearance-510k-filing-follows-fda-feedback-from-successful-pre-submission-meeting
Elutia Submits CanGarooRM Antibiotic-Eluti...
12/18/2023 13:02:33

Elutia Inc. (NASDAQ:ELUT) today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administra...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION